Researchers test mRNA technology for universal flu vaccine
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.
The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer PFE.N with BioNTech 22UAy.DE, and by Moderna MRNA.O. It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
"The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs," study leader Scott Hensley of the Perelman School of Medicine at the University of Pennsylvania said in a statement.
Unlike standard flu vaccines that deliver one or two versions of hemagglutinin, the experimental vaccine includes 20 different types in the hope of getting the immune system to recognize any flu virus it might encounter in the future.
In lab experiments, vaccinated animals' immune systems recognized the hemagglutinin proteins and defended against 18 different strains of influenza A and two strains of influenza B. Antibody levels induced by the vaccine remained unchanged for at least four months, according to a report published in the journal Science.
The vaccine reduced signs of illness and protected from death even when the ferrets were exposed to a different type of flu not in the vaccine, the researchers said.
Moderna and Pfizer both have mRNA flu vaccines in late-stage human trials, and GSK GSK.L and partner CureVac 5CV.DE are testing an mRNA flu vaccine in an early-stage safety trial in humans. These vaccines are designed to defend against only four recently-circulating influenza strains but could theoretically be changed up each year.
The universal flu vaccine, if successful in human trials, would not necessarily prevent infection. The goal is to provide durable protection against severe disease and death, Hensley said.
Questions remain regarding how to judge efficacy and potential regulatory requirements for a vaccine against possible future viruses that are not currently circulating, Alyson Kelvin and Darryl Falzarano of the University of Saskatchewan, Canada, wrote in a commentary published with the study.
While the promising results with the new vaccine "suggest a protective capacity against all subtypes of influenza viruses, we cannot be sure until clinical trials in volunteers are done," Adolfo García-Sastrem, director of the Institute for Global Health and Emerging Pathogens at Mount Sinai Hospital in New York, said in a statement.
Reporting by Nancy Lapid; Editing by Christine Soares and Bill Berkrot
COVID-19 COVERAGE
CTVNews.ca Top Stories
BREAKING | B.C. reveals plan for decriminalization of small amounts of drugs for personal use
British Columbia is taking a major step forward in its fight against the province’s deadly overdose crisis by decriminalizing the possession of a small amount of certain illicit drugs for personal use.

L'Arche says co-founder Jean Vanier sexually abused 25 women
A report commissioned by a non-profit organization founded by the late Jean Vanier says the Canadian sexually abused 25 women during his decades with the group.
Girl, 6, dead after accident at ski resort north of Montreal on Sunday
A six-year-old girl died in hospital Sunday night after being involved in an incident at the Val-Saint-Côme ski resort in Lanaudiere. Quebec police are investigating, though details into the event are not yet known. Officers indicated that it involved a T-bar lift, but they were not able to say more.
Why adding a bit of milk to your morning coffee might be good for you
Adding some milk to your morning coffee may boost the body's anti-inflammatory response, new research out of Denmark shows.
Michael Jackson's nephew to star in King of Pop biopic
Michael Jackson's 26-year-old nephew, Jaafar Jackson, will play the King of Pop in the planned biopic "Michael" to be directed by Antoine Fuqua.
WHO: COVID-19 still an emergency but nearing 'inflection' point
The coronavirus remains a global health emergency, the World Health Organization chief said Monday, after a key advisory panel found the pandemic may be nearing an 'inflection point' where higher levels of immunity can lower virus-related deaths.
New alcohol recommendations could speed up changing drinking habits: businesses
New guidance for drinking alcohol could speed up changing consumer drinking habits as younger generations drink less and non-alcoholic beverages become more popular, advocates and business owners in the beverage industry say.
Health, economy, crime top issues of concern as House of Commons resumes
Members of Parliament return to Ottawa to resume sitting for the first time in 2023 on Monday, with the state of Canada's health-care system, the health of the Canadian economy, and rates of violent crime in this country all top of mind.
Quebec minister calls on new anti-Islamophobia representative to step down over Bill 21 comments
Quebec's minister responsible for secularism, Jean-Francois Roberge, has called on Canada’s new special anti-Islamophobia advisor Amira Elghawaby to apologize and step down.